Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This 8 week at home study is designed to explore efficacy endpoints and evaluate the safety of intranasal Bremelanotide in women with Female Sexual Arousal Disorder. Efficacy will be assessed vs. a parallel placebo group.
Epistemonikos ID: b00b919d84828e06e738ac179a14bdd17ab6e265
First added on: May 04, 2024